1 / 5

S. Guinot - First Evitherm Industry Forum Meeting – September the 15 th 2003 - Paris

DRUG Development in Pharmacuetical Pre-clinical Research. Pre-clinical research and development objective :. To obtain a molecule that is active in animals, ready to be tested in humans witn minimum risk and maximum chances of success. Pharmaceutical sciences :. Preformulation

knoton
Télécharger la présentation

S. Guinot - First Evitherm Industry Forum Meeting – September the 15 th 2003 - Paris

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DRUG Development in Pharmacuetical Pre-clinical Research • Pre-clinical research and development objective : • To obtain a molecule that is active in animals, • ready to be tested in humans witn minimum risk and • maximum chances of success. • Pharmaceutical sciences : • Preformulation • Clinical Development • Pharmaceutical Development • Regulatory Affairs S. Guinot - First Evitherm Industry Forum Meeting – September the 15th 2003 - Paris

  2. Pharmaceutical Sciences – Preformulation • Role : establish the physicochemical and biopharmaceutical profile of pharmaceutical compounds to help selection of candidates for clinical administration. • Disciplines : • Chemical analysis : solubility and chemical stability • Physical analysis : solid state profile and stability, polymorphism • Biopharmacy : physico-chemistry and formulation for in vivo • administration S. Guinot - First Evitherm Industry Forum Meeting – September the 15th 2003 - Paris

  3. Purification Crystallisation Formulation Storage Synthesis Administration Storage Distribution Physico-chimistry in the body Preformulation – Physical analysis * * Physical form of the drug is CRUCIAL ! * * S. Guinot - First Evitherm Industry Forum Meeting – September the 15th 2003 - Paris

  4. Physical form of the drug is CRUCIAL ! • to guarantee a good bioavailability • to ensure physical stability during formulation, storage and processing • Most stable and appropriate crystalline form wanted • Solid state parameters needed : • crystallinity * • « physical » purity * • melting temperature * • decomposition temperature * • hygroscopicity • shape and particle size distribution • texture • polymorphic form in general * * Can be obtained by thermal methods S. Guinot - First Evitherm Industry Forum Meeting – September the 15th 2003 - Paris

  5. Thermal info overall needs in a pharmaceutical sciences context • Info (any kind) about thermal analysis and microcalorimetry • equipment suppliers • Basic advices for equipment maintenance and calibration • Thermal database for APIs and excipients • Basic technical and academic knowledge concerning thermal methods • (DSC, MDSC, TGA, Hres TGA, coupling…) • Support for complex thermal methods choice of parameters • (MDSC, HiRes TGA…) • Contacts with experts in the field • Items and/or web links for thermal analysis and calorimetry trainings, workshops, conferences, outsourcing, consultancy, jobs, people… • Thermal bibliography sorted for specific field of interest • (food, pharmaceuticals-polymorphism, cosmetics…) • Support for complex data interpretation Low priority High priority S. Guinot - First Evitherm Industry Forum Meeting – September the 15th 2003 - Paris

More Related